Zoe Cooper
Fresenius expands biosimilars portfolio in big deal
Fresenius expands biosimilars portfolio through big deal with WuXi Biologics, gaining option rights on up to 37 candidates.
Democrats win Congress but Trump veto looms
Trump veto looms as Democrats win Congress, sparking fresh trade hurdles, oversight hearings and plans to roll back President Trump's tariff measures.
G20 Diplomats Face Deep Rifts Over Global Conflicts
Diplomats face deep rifts over wars and trade at the G20 meeting in Atlanta, with Secretary of State Marco Rubio chairing the…
Patients Struggle to Find Accepting Doctors Nationwide
Patients struggle to find accepting doctors nationwide, facing repeated rejections despite Medicare coverage and family recommendations.
Brewers Win World Series Opener on Defense
Brewers World Series defense leads to 3-2 opener win over Rays, as defensive stops and key errors shift momentum in their favor.
Targeted Hemodynamic Therapy Increases Death Risk in Major Surgery
Targeted hemodynamic therapy may increase the risk of death during high-risk abdominal surgery, according to findings from the multicenter PELICAN trial involvi
Gene therapy startup targets ADPKD’s root cause
Estuary Biotherapeutics targets ADPKD’s root cause with gene therapy, offering potential to stop or reverse cyst growth before irreversible kidney damage occurs
Microbiome Changes Linked to Severe Long COVID Symptoms
Research links microbiome changes in the oral and lung regions to severe long COVID symptoms, offering insights into persistent health issues.
Intellia’s CRISPR Therapy Moves Toward FDA Approval for HAE
CRISPR HAE therapy by Intellia may receive FDA approval in March 2027, offering a one-time treatment to lower kallikrein and bradykinin levels.
Treating Fibrotic Disease by Reversing Cellular Aging
Scientists are exploring a way to treat fibrotic disease by reactivating a cellular process that naturally declines with age, potentially reducing tissue…